ORXOY News and Press, Orexo Ab Sp/Adr From 02/08/24

2024-02-08 06:30:09 ET More on Orexo AB Historical earnings data for Orexo AB Financial information for Orexo AB Read the full article on Seeking Alpha For further details see: Orexo AB GAAP EPS of -SEK0.54, revenue of SEK166M

Orexo Interim Report Q4 2023, incl. Full Year Report PR Newswire UPPSALA, Sweden , Feb. 8, 2024 /PRNewswire/ -- Positive EBITDA in H2 setting the target for FY 2024 Q4 2023 highlights Total net revenues of SEK 166.0 m (156.1) EBITDA...

Orexo's OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC PR Newswire OX640 is Orexo's nasal epinephrine powder product for the acute treatment of severe allergic reactions including anaphylaxis, based on the company´s propriet...

Orexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose PR Newswire OX124 is based on Orexo´s world-class drug delivery platform, amorphOX®, and is designed to reverse the effects of the most powerf...

2023-11-02 10:37:31 ET More on Orexo AB Historical earnings data for Orexo AB Financial information for Orexo AB For further details see: Orexo AB reports Q3 interim results

Orexo Q3 2023 Interim Report PR Newswire Big step forward in launching OX124 in the US UPPSALA, Sweden , Nov. 2, 2023 /PRNewswire/ -- Q3 2023 highlights ›     Total net revenues of SEK 156.1 m (161.0) › &#...

Orexo announces changes in the company´s Board of Directors PR Newswire UPPSALA, Sweden , Oct. 27, 2023 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), announces that Robin Evers , Senior Vice President, Head of Global Regulatory Affairs &am...

Orexo´s Nomination Committee for the Annual General Meeting 2024 PR Newswire UPPSALA, Sweden , Oct. 26, 2023 /PRNewswire/ -- Prior to the Annual General Meeting (AGM) in 2024, that will take place on April 26 , a Nomination Committee has been appointed. ...

Report from Orexo´s extraordinary general meeting PR Newswire STOCKHOLM , Oct. 26, 2023 /PRNewswire/ -- Election of new member of the board of directors The extraordinary general meeting in Orexo AB (publ) on 26 October 2023 resolved, in accordan...

Orexo announces data from the MODIA® study evaluating impact on use of illicit opioids PR Newswire The six-month randomized controlled trial (RCT) enrolled 437 participants at 36 sites across the US The study demonstrated no statistically significant difference betwee...